|
| | 8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one Basic information |
| Product Name: | 8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one | | Synonyms: | 8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one;4-[6-(8-Cyclopentyl-5-methyl-7-oxo-6-vinyl-7,8-dihydro-pyrido[2,3-d]pyrimidin-2-ylamino)-pyridin-3-yl]-piperazine-1-carboxylic acid tert-butyl ester;Palbociclib Impurity E;Palbociclib impurity 29/8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one;Palbociclib-6;Palbociclib Impurity 40;Palbociclib 1-?Hydroxyethyl;Pyrido[2,3-d]pyrimidin-7(8H)-one, 8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]- | | CAS: | 1376615-91-6 | | MF: | C24H31N7O2 | | MW: | 449.55 | | EINECS: | | | Product Categories: | | | Mol File: | 1376615-91-6.mol | ![8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one Structure](CAS/20180629/GIF/1376615-91-6.gif) |
| | 8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one Chemical Properties |
| | 8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one Usage And Synthesis |
| Uses | Palbociclib 1-?Hydroxyethyl is an impurity of Palbociclib(P139900). Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
| | 8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one Preparation Products And Raw materials |
|
